ZMC(SH:600216) Xin Lang Cai Jing·2025-11-13 09:18Core Viewpoint - Zhejiang Medicine announced the approval of its 2025 restricted stock incentive plan on October 27, 2025, indicating a strategic move to enhance employee motivation and align interests with shareholders [1] Summary by Relevant Sections - Incentive Plan Details - The company has established a restricted stock incentive plan for 2025, which aims to incentivize employees and improve performance [1] - Insider Trading Self-Examination - The company conducted a self-examination of insider trading activities among individuals with knowledge of the incentive plan, covering a period of six months prior to the announcement [1] - Findings of the Self-Examination - The self-examination revealed that some individuals did trade the company's stock during the review period; however, these trades were based on personal market judgment and were not related to the incentive plan [1] - No evidence was found of insider information being used for trading or any instances of insider trading [1]